| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 8 | |
| #2 | Australia | 6 | |
| #3 | Canada | 6 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | African Regional Industrial Property Organization | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Machines | |
| #4 | Measurement | |
| #5 | Computer technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Therapeutic chemical compounds | |
| #5 | Unspecified technologies | |
| #6 | Analysing materials | |
| #7 | Measuring microorganism processes | |
| #8 | Speech analysis |
| # | Name | Total Patents |
|---|---|---|
| #1 | Smith Jonathan F | 15 |
| #2 | Pushko Peter | 15 |
| #3 | Parker Michael D | 6 |
| #4 | Ulrich Robert G | 5 |
| #5 | Schmaljohn Alan L | 5 |
| #6 | Lee John S | 5 |
| #7 | Hevey Michael C | 4 |
| #8 | Negley Diane L | 4 |
| #9 | Welkos Susan L | 3 |
| #10 | Schmidt James J | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2002227232A1 | Bacterial superantigen vaccines | |
| AU9477101A | High throughput assays for the proteotytic activities of clostridial neurotoxins | |
| EP1146900A2 | Dna vaccines against hantavirus infections | |
| CA2354374A1 | Live attenuated venezuelan equine encephalitis vaccine | |
| EP1097212A2 | Anthrax vaccine | |
| AU4709099A | Marburg virus vaccines |